On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases

BACKGROUND: Abnormal cardiac uptake of (123)I-metaiodobenzylguanidine ((123)I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Planar imaging is generally used to assess cardiac sympathetic dysfunction in (123)I-MIBG scint...

Descripción completa

Detalles Bibliográficos
Autores principales: Odagiri, Hayato, Baba, Toru, Nishio, Yoshiyuki, Iizuka, Osamu, Matsuda, Minoru, Inoue, Kentaro, Kikuchi, Akio, Hasegawa, Takafumi, Aoki, Masashi, Takeda, Atsushi, Taki, Yasuyuki, Mori, Etsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824520/
https://www.ncbi.nlm.nih.gov/pubmed/27055151
http://dx.doi.org/10.1371/journal.pone.0152746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824520/
https://www.ncbi.nlm.nih.gov/pubmed/27055151
http://dx.doi.org/10.1371/journal.pone.0152746

Ejemplares similares